Nearly one million doses of vaccine expected to be produced

2024-08-28 15:06:56

The director of the Africa Centers for Disease Control and Prevention (Africa CDC) is requesting a technology transfer expected to make nearly 1 million doses of MPOX available in Africa, the epicenter of the virus’s resurgence, the director of the Africa Centers for Disease Control and Prevention (Africa CDC) announced Wednesday, August 28. vaccine.

“We are working hard to secure nearly a million doses of vaccine” Dr. Jean Kaseya, director-general of the Africa Centers for Disease Control and Prevention, announced progress in the development of the MPOX vaccine at a meeting of the World Health Organization’s Regional Committee for Africa in Brazzaville, Congo. Dr Kasea said 215,000 doses of vaccine had been administered “safe” From Danish manufacturer Bavarian Nordic.

READ ALSO | Article reserved for our Mpox subscribers: Genetic characteristics of the viruses involved in the “fight against humanity”

Add to your selection

Several countries, including Spain (500,000 doses), France and Germany (100,000 doses), have pledged to provide vaccines to African countries on the front lines of the fight against the epidemic. “We told Bavarian Nordic we need to transfer technology to African manufacturers” wait “We believe that soon, the mpox vaccine will be produced in Africa””, added Dr. Kaseya. According to him, “As of August 27, we have 22,863 suspected cases and 622 deaths” Related to various MPOX branches on the African continent.

Emergence of new variants

Regarding confirmed cases, “We haven’t talked much about it because we still have countries with testing rates below 30%, and we still have countries with a lot of quality and shipping challenges.”he clarified.

According to the World Health Organization, as of August 25, 2024, 5,281 cases of MPOX have been confirmed on the African continent, and 60% of suspected cases have tested positive. WHO estimates that the international response to pox will require US$135 million over the next six months. On Tuesday, the company launched an appeal to raise $87.4 million to support its own anti-pandemic activities.

READ ALSO | Article reserved for Mpox subscribers in Democratic Republic of Congo: Responses have been reorganized

Add to your selection

The resurgence of MPOX in Africa, affecting the Democratic Republic of the Congo (DRC) and 12 other countries on the continent, notably Burundi, Kenya, Rwanda and Uganda, and the emergence of new variants (1b) have prompted the World Health Organization to trigger the August 14 The highest alert level in the world today.

Mpox, formerly known as monkeypox, is a viral disease that spreads from animals to humans but also among humans, causing fever, muscle pain and skin lesions.

Reuse this content
1724919552
#million #doses #vaccine #expected #produced

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.